The IPO4 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population in which the IPO4 gene, encoding importin-4, has been disrupted. This loss-of-function model is generated in HEK293T cells, providing a genetically heterogeneous pool of knockout cells suitable for studying the functional consequences of IPO4 ablation. The polyclonal format offers robust representation of gene disruption events without single-cell cloning, making it ideal for applications requiring population-level analysis such as functional genomics and signaling studies. The cells are derived from the human embryonic kidney HEK293T line and are expanded after CRISPR/Cas9-mediated gene targeting, ensuring a broad allelic spectrum of mutations across the population.
HEK293T is a widely used derivative of the HEK293 cell line that stably expresses the SV40 large T antigen. This modification enables episomal replication of plasmids containing the SV40 origin of replication, conferring exceptionally high transfection efficiency and transient protein expression. As human embryonic kidney epithelial cells, HEK293T cells are permissive for many experimental procedures and are a gold standard for biochemical and cell-based assays. Their robust growth characteristics and ease of manipulation make them an ideal host for generating knockout models to dissect complex cellular processes such as nucleocytoplasmic transport and ribosomal biogenesis.
IPO4 encodes importin-4, a karyopherin that functions as a nuclear transport receptor mediating the RanGTP-dependent import of ribosomal proteins and other NLS-containing cargo. Importin-4 recognizes nuclear localization signals on substrates such as RPS3A and RPL4, orchestrates their docking at the nuclear pore complex through interactions with nucleoporins including NUP62, and facilitates translocation into the nucleus upon RanGTP binding. This process is tightly regulated by the Ran GTPase gradient, post-translational modifications, and cell cycle signals. In the nucleus, GTP hydrolysis by Ran releases the cargo, enabling importin-4 recycling via export factors like CSE1L. Partnering with importin beta (KPNB1), IPO4 thus sits at the nexus of ribosomal protein import and ribosome assembly pathways, directly influencing cell growth and proliferation.
Disruption of IPO4 in HEK293T cells provides a powerful system to interrogate the role of importin-4 in nucleocytoplasmic trafficking and ribosome biogenesis. Given the central importance of ribosomal proteins for translation, loss of IPO4 function may perturb the nuclear accumulation of key ribosomal components, leading to defects in ribosome assembly and altered proliferative capacity. This knockout model enables researchers to dissect the import pathway in a cellular context characterized by high metabolic and translational activity. It is particularly relevant for investigating the interplay between nuclear transport and cell cycle progression, as well as potential contributions to ribosomopathies and cancer biology.
The IPO4 Knockout HEK293T Polyclonal Cells are suitable for a wide range of research applications. Experimental approaches include immunofluorescence microscopy to visualize mislocalization of cargo proteins such as ribosomal subunits, co-immunoprecipitation to assess disrupted import complexes, and western blotting to quantify importin-4 expression levels. Functional assays can employ luciferase-based nuclear transport reporters and flow cytometry to monitor cell cycle progression in the absence of IPO4. The polyclonal population is also valuable for protein-protein interaction studies and functional genomics screens aimed at identifying modifiers of the importin-4 pathway. For further information, including pricing and availability, please contact Ascent Research.
